📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
32
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
📉 Score Deterioration
40%
• Score rose 20 points recently (worsening)
🔄 Reverse Split
30%
• 50-day avg $1.90 approaching $1 threshold
📜 Warrant Exercise
15%
• Warrant overhang: 8.4% of shares outstanding
💹 Market Data
Market Cap$7.83M
Shares Outstanding3.67M
Float2.31M
Cash$36.9K
Debt$115.5K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 47.3% shares (2025Q4 vs prior)
2 institutional holders · 32.5K shares
#1
DRW Securities, LLC
31.1K shares
#2
UBS Group AG
1.4K shares
📉 Short Interest
Short Interest8.9K
Days to Cover1.0
% of Float0.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
8-K
8K EVENT
Apr 28, 2026
3
FORM3
Apr 24, 2026
4
INSIDER TRANSACTION
Apr 24, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GITS
📊 GITS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GITS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.